Mulberry Coffee Bean Extract Composition for Glucose Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmaceuticals for managing abnormal glucose levels, such as diabetes and obesity, are burdened by side effects and long-term ineffectiveness, and there is a need for a dietary composition that can effectively regulate blood glucose and insulin levels without these drawbacks.
Innovation Solution
A dietary composition comprising mulberry extract, green coffee extract, and white bean extract, optionally with dietary fibers, which when combined, significantly reduce blood glucose levels, improve glucose homeostasis, and manage insulin levels, thereby addressing metabolic disorders like diabetes and obesity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmaceuticals are used to treat diabetes and obesity, then blood glucose levels are reduced, but side effects and long-term ineffectiveness occur
Solution Approach 1:
The patent replaces long-term pharmaceutical treatment with a natural dietary composition that can be consumed repeatedly without accumulating harmful effects. The mulberry, green coffee, and white bean extracts provide sustained glucose management through natural mechanisms rather than pharmaceutical intervention, eliminating side effects while maintaining effectiveness over time.
Solution Approach 2:
The patent combines three different natural extracts (mulberry, green coffee, and white bean) into a composite dietary composition. Each extract contributes unique bioactive compounds that work synergistically to manage blood glucose levels, providing comprehensive metabolic support without the side effects associated with single-pharmaceutical approaches.
2Reliability
If single plant extracts are used to reduce blood glucose, then some glycemic reduction effect is achieved, but the effect is inconsistent and random
Solution Approach 1:
The patent merges three different plant extracts (mulberry, green coffee, and white bean) into a single dietary composition. This combination creates a synergistic effect where the bioactive compounds from each plant work together to provide consistent and reliable blood glucose reduction, overcoming the inconsistent effects observed when using single extracts alone.
Solution Approach 2:
The patent creates a composite dietary composition combining multiple plant extracts with complementary mechanisms of action. This composite approach ensures consistent glycemic control by utilizing the combined therapeutic properties of different plants, making the overall effect more reliable and predictable than individual extracts.
3Reliability
If pharmaceuticals are used for long-term treatment, then initial glucose control is achieved, but tolerance develops and deterioration continues
Solution Approach 1:
The dietary composition enables the body's own metabolic systems to maintain glucose homeostasis through natural mechanisms. The bioactive compounds from the plants support endogenous insulin sensitivity and glucose metabolism without creating external dependency, allowing the body to self-regulate blood glucose levels consistently over the long term without developing tolerance.
4Reliability
If a combination of three plant extracts is used, then significant blood glucose reduction is achieved, but the complexity of the composition increases
Solution Approach 1:
The patent combines three plant extracts into a single integrated dietary composition that can be conveniently administered as one product. This merging approach maintains the therapeutic benefits of multiple plants while simplifying the user experience, eliminating the need to take separate supplements for each plant extract.
Data Source
AI summary
The present invention provides dietary compositions comprising mulberry extract, coffee extract, bean extract, optionally, dietary fibers, and a nutraceutically acceptable carrier. The present invention further provides methods for preventing the increase in postprandial hyperglycemia and hypoglycemia, hyperinsulinemia and diseases and disorders associated therewith, including, endothelial dysfunction, inflammatory conditions, oxidative stress, hyperlipidemia, and consecutive pathologies like insulin resistance, diabetes, visceral obesity, hypertension and cardiovascular diseases.